EXtubation Related Complications - the EXTUBE Study (EXTUBE)
EXTUBE
2 other identifiers
observational
3,000
8 countries
32
Brief Summary
EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and describing clinical practices related to extubation after general anesthesia or after critical illness in the operating room (OR), out of OR anesthesia location or intensive care unit (ICU).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2025
32 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 28, 2024
CompletedFirst Posted
Study publicly available on registry
June 5, 2024
CompletedStudy Start
First participant enrolled
April 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
June 12, 2026
July 1, 2025
1.6 years
March 28, 2024
June 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
At least one of the following, occurring within 60minutes after extubation (composite outcome): i) Severe hypoxemia ii) Cardiac arrest iii) Need for airway management
The primary outcome will be the occurrence of at least one of the following (composite outcome) occurring within 60 minutes after the end of extubation: i) Severe hypoxemia (oxygen saturation as measured by pulse oximetry falls below SpO2 \< 80% for \> 5 minutes) ii) Cardiac arrest iii) Need for airway management (reintubation, insertion of a supraglottic airway, bag-mask ventilation).
Within 60 minutes after the end of extubation
Secondary Outcomes (12)
Difficult airway and complications related to airway management if reintubation is required
Within 60 minutes after the end of extubation
Planned and unplanned non-invasive respiratory support
Within 60 minutes after the end of extubation
Emergency front of neck airway
Within 60 minutes after the end of extubation
Cardiac arrhythmia requiring chemical or electrical treatment
Within 60 minutes after the end of extubation
Severe Hypotension
Within 60 minutes after the end of extubation
- +7 more secondary outcomes
Eligibility Criteria
All adult patients (≥18 years old) undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU during the specified enrollment window
You may qualify if:
- Adult patients (≥18 years old)
- Undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU
- Undergoing extubation during the specified enrollment window
You may not qualify if:
- Patients will be excluded if the extubation is performed in the context of withdrawal of life support measures,
- Patients will be excluded if the extubation is performed for tracheostomy decannulation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (32)
Banner University Medical Centre
Tucson, Arizona, 85724-5114, United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
University of Florida
Gainesville, Florida, 32608, United States
The University of Chicago
Chicago, Illinois, 60637, United States
Oregon Health & Science University
Portland, Oregon, 97239, United States
The University of Texas Health Science Center
Houston, Texas, 77030, United States
Royal North Shore Hospital
Sydney, New South Wales, 2065, Australia
The Northern Hospital
Melbourne, Victoria, 3076, Australia
Austin Hospital
Melbourne, Victoria, 3084, Australia
Eastern Health - Box Hill Hospital
Melbourne, Victoria, 3128, Australia
Eastern Health - Maroondah Hospital
Melbourne, Victoria, 3135, Australia
Eastern Health - Angliss Hospital
Melbourne, Victoria, 3156, Australia
Surrey Memorial Hospital
Surrey, British Columbia, V3V 1Z2, Canada
The Moncton Hospital
Moncton, New Brunswick, E1C 4B7, Canada
Sunnybrook Hospital
North York, Ontario, M4N 3M5, Canada
Niagara Health - Marotta Family Hospital
Saint Catharines, Ontario, L2S 0A9, Canada
St. Michael's Hospital
Toronto, Ontario, M5B 1W8, Canada
Mount Sinai Hospital
Toronto, Ontario, M5G 1X5, Canada
University Health Network - Toronto General Hospital
Toronto, Ontario, M5G 2C4, Canada
University Health Network - Toronto Western Hospital
Toronto, Ontario, M5T 2S8, Canada
Centre hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, H2X 0C1, Canada
Hospital Internacional de Colombia
Piedecuesta, Colombia
Mayo University Hospital
Castlebar, F23 H529, Ireland
Cork University Hospital
Cork, T12 DFK4, Ireland
Mater Misericordiae University Hospital
Dublin, D07 R2WY, Ireland
Galway University Hospitals
Galway, H91 YR71, Ireland
University Hospital Waterford
Waterford, X91 ER8E, Ireland
Southland Hospital
Invercargill, 9812, New Zealand
Rotorua Hospital
Rotorua, 3010, New Zealand
Tan Tock Seng Hospital
Singapore, 308433, Singapore
Royal United Hospitals Bath
Bath, BA1 3NG, United Kingdom
Freeman Hospital
Newcastle upon Tyne, NE7 7DN, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Matteo Parotto, MD, PhD
UHN
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2024
First Posted
June 5, 2024
Study Start
April 14, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
June 12, 2026
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share